Immunome 宣布以每股 20 美元的价格公开发行 2 亿美元股票，并提供 30 天增发 150 万股的选择权，截止日期为 2024 年 2 月 16 日。 Immunome announces a $200M public stock offering at $20/share, with a 30-day option for additional 1.5M shares, closing Feb 16, 2024.

生物技术公司Immunome宣布以每股20美元的价格公开发行1000万股股票，旨在筹集2亿美元。 Biotech company Immunome announces a public offering of 10 million shares at $20 per share, aiming to raise $200 million. 此次发行取决于市场情况，预计将于 2024 年 2 月 16 日结束。 The offering is subject to market conditions and is expected to close on February 16, 2024. Immunome 专注于发现和开发抗体疗法，打算将所得款项用于一般企业用途和靶向癌症疗法的开发。 Immunome, which focuses on discovering and developing antibody therapeutics, intends to use the proceeds for general corporate purposes and the development of targeted cancer therapies. 承销商拥有 30 天的选择权，可以额外购买最多 150 万股股票。 Underwriters have a 30-day option to purchase up to an additional 1.5 million shares.